Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400093112Phase 4Recruiting
Phase 4, open-label trial of ciprofol (2 arms), sponsored by Shidong Hospital. Primary endpoint: Amount of intravenous anesthetic used to induce disappearance of eyelash reflex. Started Nov 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400093112.